Table 4 Clinical characteristics and imaging features of patients between RMPP combined with PB group and RMPP group in the validation dataset
Clinical characteristics | Patients (n = 173) | RMPP combined with PB (n = 53) | RMPP (n = 120) | P |
|---|---|---|---|---|
Age, years | 6.7 ± 2.6 | 6.9 ± 2.5 | 6.5 ± 2.6 | 0.269 |
Sex (male/female) | 86/87 | 25/28 | 61/59 | 0.657 |
Fever (n, %) | 173 (100%) | 53 (100%) | 120 (100%) | 1.000 |
Cough (n, %) | 173 (100%) | 53 (100%) | 120 (100%) | 1.000 |
Patients with multiple FOB (n, %) | 49 (28.3%) | 24 | 23 (19.2%) | 0.000 |
Peak body temperature, °C | 39.8 ± 0.5 | 40.1 ± 0.6 | 39.6 ± 0.4 | 0.000 |
Duration of fever, days | 10.0 ± 2.4 | 11.3 ± 2.7 | 9.4 ± 2.0 | 0.000 |
Duration of hospitalization, days | 7.8 ± 2.2 | 8.8 ± 2.6 | 7.4 ± 1.9 | 0.000 |
Fever duration before FOB, days | 8.0 ± 2.5 | 8.3 ± 3.2 | 7.9 ± 2.0 | 0.398 |
Hypoxemia (n, %) | 25 (14.5%) | 11 (20.8%) | 14 (11.7%) | 0.117 |
Glucocorticoid (n, %) | 134 (77.9%) | 49 (92.5%) | 85 (71.4%) | 0.002 |
IVIG (n, %) | 9 (5.2%) | 5 (9.4%) | 4 (3.3%) | 0.135 |
Admission to ICU (n, %) | 5 (2.9%) | 2 (3.8%) | 3 (2.5%) | 0.643 |
Atelectasis (n, %) | 67 (39.0%) | 36 (67.9%) | 31 (26.1%) | 0.000 |
Pleural effusion (n, %) | 59 (34.3%) | 32 (60.4%) | 27 (22.7%) | 0.000 |
Pleural thickening (n, %) | 101 (58.7%) | 30 (56.6%) | 71 (59.7%) | 0.707 |